BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12004057)

  • 1. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme.
    Toth M; Hernandez-Barrantes S; Osenkowski P; Bernardo MM; Gervasi DC; Shimura Y; Meroueh O; Kotra LP; Gálvez BG; Arroyo AG; Mobashery S; Fridman R
    J Biol Chem; 2002 Jul; 277(29):26340-50. PubMed ID: 12004057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing.
    Osenkowski P; Meroueh SO; Pavel D; Mobashery S; Fridman R
    J Biol Chem; 2005 Jul; 280(28):26160-8. PubMed ID: 15901740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.
    Hernandez-Barrantes S; Toth M; Bernardo MM; Yurkova M; Gervasi DC; Raz Y; Sang QA; Fridman R
    J Biol Chem; 2000 Apr; 275(16):12080-9. PubMed ID: 10766841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
    Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
    J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase.
    Toth M; Osenkowski P; Hesek D; Brown S; Meroueh S; Sakr W; Mobashery S; Fridman R
    Biochem J; 2005 Apr; 387(Pt 2):497-506. PubMed ID: 15560752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
    Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
    J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K; Lohi J; Valtanen H; Keski-Oja J
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
    Bernardo MM; Fridman R
    Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP.
    Hernandez-Barrantes S; Shimura Y; Soloway PD; Sang QA; Fridman R
    Biochem Biophys Res Commun; 2001 Feb; 281(1):126-30. PubMed ID: 11178970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.
    Toth M; Bernardo MM; Gervasi DC; Soloway PD; Wang Z; Bigg HF; Overall CM; DeClerck YA; Tschesche H; Cher ML; Brown S; Mobashery S; Fridman R
    J Biol Chem; 2000 Dec; 275(52):41415-23. PubMed ID: 10998420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP).
    Zucker S; Drews M; Conner C; Foda HD; DeClerck YA; Langley KE; Bahou WF; Docherty AJ; Cao J
    J Biol Chem; 1998 Jan; 273(2):1216-22. PubMed ID: 9422789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.
    Stanton H; Gavrilovic J; Atkinson SJ; d'Ortho MP; Yamada KM; Zardi L; Murphy G
    J Cell Sci; 1998 Sep; 111 ( Pt 18)():2789-98. PubMed ID: 9718371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
    Lehti K; Valtanen H; Wickström SA; Lohi J; Keski-Oja J
    J Biol Chem; 2000 May; 275(20):15006-13. PubMed ID: 10748199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP.
    Cho JA; Osenkowski P; Zhao H; Kim S; Toth M; Cole K; Aboukameel A; Saliganan A; Schuger L; Bonfil RD; Fridman R
    J Biol Chem; 2008 Jun; 283(25):17391-405. PubMed ID: 18413312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.
    Annabi B; Pilorget A; Bousquet-Gagnon N; Gingras D; Béliveau R
    Biochem J; 2001 Oct; 359(Pt 2):325-33. PubMed ID: 11583578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase.
    Wu YI; Munshi HG; Sen R; Snipas SJ; Salvesen GS; Fridman R; Stack MS
    J Biol Chem; 2004 Feb; 279(9):8278-89. PubMed ID: 14670950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines.
    Maquoi E; Frankenne F; Baramova E; Munaut C; Sounni NE; Remacle A; Noël A; Murphy G; Foidart JM
    J Biol Chem; 2000 Apr; 275(15):11368-78. PubMed ID: 10753951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.
    Egawa N; Koshikawa N; Tomari T; Nabeshima K; Isobe T; Seiki M
    J Biol Chem; 2006 Dec; 281(49):37576-85. PubMed ID: 17050542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.